You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RLAY Sale Disclosure
Catinazzo Thomas · SEC Form 4 · Filed Sep 9, 2026
Sale
Calculated transaction value
$335.56K
Catinazzo Thomas Chief Financial Officer
RLAY
Relay Therapeutics
RLAY
Transaction date
Sep 8, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 1 day later
RLAY daily price context
Close on/before transaction
$19.11
Sep 8, 2026
First close after public filing
$18.89
Sep 10, 2026
30-day return after filing
-5.35%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 17,717 shares @ $18.94
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-386464
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$335.56K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Relay Therapeutics, Inc. RLAY Current | Sale | Sep 8, 2026 | $335.56K |